Correlation Between Aerovate Therapeutics and Sino Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Sino Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Sino Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Sino Biopharmaceutical Ltd, you can compare the effects of market volatilities on Aerovate Therapeutics and Sino Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Sino Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Sino Biopharmaceutica.
Diversification Opportunities for Aerovate Therapeutics and Sino Biopharmaceutica
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aerovate and Sino is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Sino Biopharmaceutical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sino Biopharmaceutical and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Sino Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sino Biopharmaceutical has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Sino Biopharmaceutica go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Sino Biopharmaceutica
Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Sino Biopharmaceutica. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.46 times less risky than Sino Biopharmaceutica. The stock trades about -0.04 of its potential returns per unit of risk. The Sino Biopharmaceutical Ltd is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 834.00 in Sino Biopharmaceutical Ltd on December 28, 2024 and sell it today you would earn a total of 104.00 from holding Sino Biopharmaceutical Ltd or generate 12.47% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Aerovate Therapeutics vs. Sino Biopharmaceutical Ltd
Performance |
Timeline |
Aerovate Therapeutics |
Sino Biopharmaceutical |
Aerovate Therapeutics and Sino Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and Sino Biopharmaceutica
The main advantage of trading using opposite Aerovate Therapeutics and Sino Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Sino Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will offset losses from the drop in Sino Biopharmaceutica's long position.Aerovate Therapeutics vs. Day One Biopharmaceuticals | Aerovate Therapeutics vs. Mirum Pharmaceuticals | Aerovate Therapeutics vs. Rocket Pharmaceuticals | Aerovate Therapeutics vs. Avidity Biosciences |
Sino Biopharmaceutica vs. Institute of Biomedical | Sino Biopharmaceutica vs. Defence Therapeutics | Sino Biopharmaceutica vs. Enlivex Therapeutics | Sino Biopharmaceutica vs. Protagenic Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |